Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition-Reference-Cited by-同舟云学术

Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition

Published:2023-07-25 Issue:8 Volume:87 Page:1047-1055
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Takashio Seiji¹,Kato Teiji²,Tashima Hikaru³,Irie Hiroki⁴,Komohara Yoshihiro⁵,Oguni Tetsuya¹,Morikawa Kei¹,Kuyama Naoto¹,Tabata Noriaki¹,Hanatani Shinsuke¹,Yamamoto Eiichiro¹,Matsushita Kenichi¹,Ueda Mitsuharu⁶,Tsujita Kenichi¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

2. Kato Orthopedics Clinic

3. Kumamoto Orthopaedic Hospital

4. Department of Emergency Medicine and Critical Care, Graduate School of Medical Sciences, Kumamoto University

5. Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University

6. Department of Neurology, Graduate School of Medical Sciences, Kumamoto University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/8/87_CJ-23-0223/_pdf

Reference31 articles.

1. 1. Izumiya Y, Takashio S, Oda S, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. J Cardiol 2018; 71: 135–143.

2. 2. Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 2017; 135: 1357–1377.

3. 3. González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015; 36: 2585–2594.

4. 4. Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G, et al. Redefining the epidemiology of cardiac amyloidosis: A systematic review and meta-analysis of screening studies. Eur J Heart Fail 2022; 24: 2342–2351.

5. 5. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133: 2404–2412.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty;ESC Heart Failure;2024-08-21

2. Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation;Circulation Journal;2024-06-25

3. Prevalence and Outcomes of Coronary Artery Disease Among Patients with Cardiac Transthyretin Amyloidosis;Journal of Coronary Artery Disease;2024

4. A Reliable Baton Passing From Orthopedic Surgeon to Cardiologist　― Cardiac Screening in Patients With Carpal Tunnel Syndrome for Early Diagnosis of Transthyretin Amyloid Cardiomyopathy ―;Circulation Journal;2023-07-25